✦ LIBER ✦
58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION
✍ Scribed by H.W. Reesink; H.L.A. Janssen; S. Zeuzem; E. Lawitz; M. Rodriguez-Torres; K. Patel; A. Chen; C. Davis; B. King; A. Levin; M.R. Hodges
- Book ID
- 117380272
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 134 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.